Clinical trial · Interventional
Stress Management Therapy in Patients Receiving Chemotherapy for Cancer
Stress Management Therapy for Patients Undergoing Chemotherapy
NCT00377130CI-TRIAL-00013629completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: A stress-management program may improve quality of life and reduce anxiety and depression in patients receiving chemotherapy for cancer. PURPOSE: This randomized clinical trial is studying how well stress management therapy works in patients receiving chemotherapy for cancer.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
| Psychological Stress | — | UNRESOLVED | — |
| Unspecified Adult Solid Tumor, Protocol Specific | Adult Solid Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Self Administered Stress Management | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- NO_INTERVENTION
- label
- Arm I- Usual psychological care
- description
- Usual psychological care- no intervention
- type
- EXPERIMENTAL
- label
- Self administered Stress Management
- description
- Self-Administered Stress Management Training Plus Usual Psychosocial Care
- interventionNames
- Other: Self Administered Stress Management
Primary outcomes (3)
- measure
- Quality of life
- timeFrame
- After 4th chemotherapy cycle
- description
- Assessed at baseline (before first chemotherapy cycle) and just before the start of the second, third and fourth chemotherapy cycles.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
INCLUSION CRITERIA: * At least 18 years of age * Newly diagnosed with cancer * Scheduled to receive a minimum of 4 cycles of intravenous chemotherapy * Able and willing to give informed consent to participate EXCLUSION CRITERIA: * Had intravenous chemotherapy prior to study entry * Are scheduled to receive radiotherapy prior to the end of the fourth cycle * Have severe depression or other severe psychiatric disorders
References
Publications (0)
Data not yet available
No reference posted for this study.